Maternal olmesartan exposure causing neonatal failure

Although angiotensin II receptor blockers (ARBs) are contraindicated during pregnancy, new cases are currently being reported. A 32-week preterm neonate was admitted after C-section due to maternal oligohydramnios. He presented with Potter phenotype, pulmonary hypoplasia with pneumothorax, systemic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Case Rep
Päätekijät: Pérez-Iranzo, Antonio, Ferreres, Ana Nos, Bou, Aranzazu Jarque
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2017
Aiheet:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695326/
https://ncbi.nlm.nih.gov/pubmed/29092961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-218921
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia